Johnson & Johnson Ordered to Pay $8 Billion to Man Who Developed Breasts After Taking Risperdal

It’s shaping up to be an expensive few years for Johnson & Johnson. On Oct. 9, a Philadelphia judge ordered the pharmaceutical and CPG behemoth to pay $8 billion to 26-year-old Nicholas Murray, who claimed that Risperdal, an anti-psychotic drug manufactured by J&J’s pharmaceutical subsidiary Janssen, made him grow breasts. Murray’s lawyers claimed Johnson &…

No Responses to “Johnson & Johnson Ordered to Pay $8 Billion to Man Who Developed Breasts After Taking Risperdal”

Post a Comment